SQZ Biotech Announces First Patient Dosed in Phase 1 Trial of SQZ-PBMC-HPV for HPV+ Tumors
30 janv. 2020 08h00 HE
|
SQZ Biotech
Trial is evaluating SQZ-PBMC-HPV as both monotherapy and in combination with a checkpoint inhibitor Multiple doses successfully manufactured for first patient in under 24 hours WATERTOWN, Mass.,...
SQZ Biotech to Present at Upcoming Investor Conferences in November & December
12 nov. 2019 08h00 HE
|
SQZ Biotech
WATERTOWN, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will...
SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies
07 nov. 2019 08h00 HE
|
SQZ Biotech
WATERTOWN, Mass. and RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), and Asklepios BioPharmaceutical, Inc. (AskBio), announced a research collaboration to...
SQZ Biotech to Present First Time Data Demonstrating Potential of Company’s Second Novel Cell Therapy Approach in Oncology - Activating Antigen Carriers (AACs)
05 nov. 2019 08h01 HE
|
SQZ Biotech
Preclinical data demonstrate SQZ AACs ability to prime antigen-specific T cell responses and drive tumor reduction in vivo SQZ to also present additional preclinical data on company’s first oncology...
SQZ Biotech to Present New Data at the Society for Immunotherapy of Cancer’s 34th Annual Meeting
31 oct. 2019 08h00 HE
|
SQZ Biotech
WATERTOWN, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will...
SQZ Biotech Announces Clearance of US IND Application for First Clinical Trial
22 oct. 2019 08h00 HE
|
SQZ Biotech
WATERTOWN, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing innovative treatments for multiple therapeutic areas, today announced that the...
SQZ Biotech Appoints Legal Life Sciences Expert, Lawrence Knopf, as General Counsel
17 sept. 2019 08h00 HE
|
SQZ Biotech
WATERTOWN, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of...
SQZ Biotech Announces Appointment of Experienced Pharmaceutical Executive Teri Loxam as Chief Financial Officer
07 août 2019 16h30 HE
|
SQZ Biotech
WATERTOWN, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of...
SQZ Biotech Strengthens Board of Directors with Appointment of Leading Cell Therapy Expert and Biotech Veteran
29 mai 2019 08h00 HE
|
SQZ Biotech
WATERTOWN, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of...
SQZ Biotech to Present at Investor Conferences in May & June
14 mai 2019 08h00 HE
|
SQZ Biotech
WATERTOWN, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will...